| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/11/2010 | WO2010127546A1 Application of microbubble on manufacturing medication for preventing new vessels in tumor from growing by combing with ultrasound to produce high intensity cavitation |
| 11/11/2010 | WO2010127541A1 A nano-emulsion injection of vinca alkaloids and the preparation method thereof |
| 11/11/2010 | WO2010101353A3 Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer |
| 11/11/2010 | WO2010092015A8 Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors |
| 11/11/2010 | WO2010086880A3 A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof |
| 11/11/2010 | WO2010080712A3 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 11/11/2010 | WO2009105256A3 Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand |
| 11/11/2010 | WO2009016498A8 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 11/11/2010 | WO2008122039A9 Selenocysteine mediated hybrid antibody molecules |
| 11/11/2010 | US20100286386 Combinatorial production of nucleotide and nucleoside (XiTP) analogues |
| 11/11/2010 | US20100286375 Carrier molecules |
| 11/11/2010 | US20100286290 Enzyme activity assay using rolling circle amplification |
| 11/11/2010 | US20100286283 Microtubule-disruptng agent and cancer cell proliferation inhibitor containing the same |
| 11/11/2010 | US20100286279 Methods of Synthesis of Certain Hydroxamic Acid Compounds |
| 11/11/2010 | US20100286276 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 11/11/2010 | US20100286269 Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents |
| 11/11/2010 | US20100286266 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 11/11/2010 | US20100286262 Ptgs2 haplotypes |
| 11/11/2010 | US20100286259 Epoxy-guaiane derivatives and treatment of cancer |
| 11/11/2010 | US20100286254 Crystalline forms of dmxaa sodium salt |
| 11/11/2010 | US20100286253 Method for treating ocular neovascularization |
| 11/11/2010 | US20100286246 Identification of novel genes coding for small temporal rnas |
| 11/11/2010 | US20100286245 Identification of novel genes coding for small temporal rnas |
| 11/11/2010 | US20100286244 RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY |
| 11/11/2010 | US20100286243 Mig-7 as a specific anticancer target |
| 11/11/2010 | US20100286241 Compositions comprising k-ras sirna and methods of use |
| 11/11/2010 | US20100286239 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation |
| 11/11/2010 | US20100286237 Pro-angiogenic genes in ovarian tumor endothelial cell isolates |
| 11/11/2010 | US20100286236 Dosage of oligonucleotides suitable for the treatment of tumors |
| 11/11/2010 | US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 11/11/2010 | US20100286232 Microrna expression profile associated with pancreatic cancer |
| 11/11/2010 | US20100286229 Modulation of Androgen Receptor for Treatment of Prostate Cancer |
| 11/11/2010 | US20100286228 Method of inhibiting intimal hyperplasia |
| 11/11/2010 | US20100286225 Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them. |
| 11/11/2010 | US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 11/11/2010 | US20100286220 HNF4alpha ANTAGONISTS AND METHODS OF USE |
| 11/11/2010 | US20100286209 Vinyl indazolyl compounds |
| 11/11/2010 | US20100286204 Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase |
| 11/11/2010 | US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide |
| 11/11/2010 | US20100286197 Carboxamide Derivatives As Therapeutic Agents |
| 11/11/2010 | US20100286196 New inhibitor of dd-peptidase and its use as antibiotic or anticancer drug |
| 11/11/2010 | US20100286195 Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/11/2010 | US20100286190 Certain substituted ureas, as modulators of kinase activity |
| 11/11/2010 | US20100286189 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 11/11/2010 | US20100286187 Method of predicting survival of a non-small-cell lung cancer patient to a chemotherapeutic treatment |
| 11/11/2010 | US20100286180 Methods of use of cyclopamine analogs |
| 11/11/2010 | US20100286179 Egfr polymorphisms predict gender-related treatment |
| 11/11/2010 | US20100286178 Compounds and uses thereof |
| 11/11/2010 | US20100286167 Dihydroxyphenyl isoindolylmethanones |
| 11/11/2010 | US20100286163 Indolo[3,2-c]quinoline compounds |
| 11/11/2010 | US20100286161 Pyrazine derivatives and their use as potassium channel modulators |
| 11/11/2010 | US20100286157 4- [3- (4-cyclopropanecarbonyl-piperazine-i-carbonyl) -4 -fluoro-benzyl] -2h-phthalaz in-1-one |
| 11/11/2010 | US20100286155 Adrenocortical carcinoma treatment |
| 11/11/2010 | US20100286146 Carboxamide compounds and their use as calpain inhibitors |
| 11/11/2010 | US20100286143 Methods and materials for genetic analysis of tumors |
| 11/11/2010 | US20100286142 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 11/11/2010 | US20100286141 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways |
| 11/11/2010 | US20100286139 Amino pyrazole compound |
| 11/11/2010 | US20100286127 Antitumor agent |
| 11/11/2010 | US20100286114 Hedgehog pathway antagonists and therapeutic applications thereof |
| 11/11/2010 | US20100286113 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 11/11/2010 | US20100286106 Methods and apparatus for treating the prostate |
| 11/11/2010 | US20100286105 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative |
| 11/11/2010 | US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses |
| 11/11/2010 | US20100286099 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| 11/11/2010 | US20100286094 Novel compounds of reverse turn mimetics and the use thereof |
| 11/11/2010 | US20100286090 Treatment of Multiple Myeloma |
| 11/11/2010 | US20100286088 3-Substituted-4-Oxo-3,4-Dihydro-Imidazo[5,1-d][1,2,3,5-Tetrazine-8-Carboxylic Acid Amides and Their Use |
| 11/11/2010 | US20100286084 Oligomer-Nucleoside Phosphate Conjugates |
| 11/11/2010 | US20100286079 Composition comprising covalent conjugates of chitosan and an acidic drug and parenteral administration |
| 11/11/2010 | US20100286075 Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same |
| 11/11/2010 | US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions |
| 11/11/2010 | US20100286064 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
| 11/11/2010 | US20100286063 GNRH agonist combination drugs |
| 11/11/2010 | US20100286062 Pharmaceutical compound |
| 11/11/2010 | US20100286061 Plasmin-inhibitory therapies |
| 11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
| 11/11/2010 | US20100286059 Use of opioid antagonists |
| 11/11/2010 | US20100286058 Assessing Chemotherapy Resistance of Colorectal Tumors by Determining Sparc Hypermethylation |
| 11/11/2010 | US20100286048 Albumin Fusion Proteins |
| 11/11/2010 | US20100286046 Modified h2 relaxin for tumor suppression |
| 11/11/2010 | US20100286044 Detection of tissue origin of cancer |
| 11/11/2010 | US20100286038 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 11/11/2010 | US20100286029 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286028 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286026 Novel protein |
| 11/11/2010 | US20100285149 Novel tetrahydropyridothiophenes |
| 11/11/2010 | US20100285144 Polymer-epothilone conjugates, particles, compositions, and related methods of use |
| 11/11/2010 | US20100285141 Compositions and methods for enhancing the activity of podophyllotoxin |
| 11/11/2010 | US20100285138 Compositions comprising nanoparticles and apoptotic agents and methods of use |
| 11/11/2010 | US20100285135 Nanoparticles For Use In Immunogenic Compositions |
| 11/11/2010 | US20100285132 Immunotherapy compositions, method of making and method of use thereof |
| 11/11/2010 | US20100285124 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological |
| 11/11/2010 | US20100285111 Self-assembling micelle-like nanoparticles for systemic gene delivery |
| 11/11/2010 | US20100285107 Short nucleic acid molecule-mediated modulation of aurora b kinase expression and combinations for use in anticancer therapy |
| 11/11/2010 | US20100285103 Medicament for treatment of tumors and the use thereof |
| 11/11/2010 | US20100285072 Method for Producing Dendritic Cells |
| 11/11/2010 | US20100285071 Purification of her-2 variants |
| 11/11/2010 | US20100285065 Modified cea nucleic acid and expression vectors |
| 11/11/2010 | US20100285064 Adjuvant composition for vaccine |